Increased expression of latent TGF-β-binding protein 4 affects the fibrotic process in scleroderma by TGF-β/SMAD signaling

Evaluation of serum concentrations of the selected cytokines in patients with localized scleroderma

(2016) Jolanta Budzyńska-Włodarczyk et al.   Postepy Dermatologii i Alergologii

Localized scleroderma: clinical spectrum and therapeutic update

(2015) Mariana Figueiroa Careta et al.   ANAIS BRASILEIROS DE DERMATOLOGIA

Association of chromosome 19 to lung cancer genotypes and phenotypes

(2015) Xiangdong Wang et al.   CANCER AND METASTASIS REVIEWS

Modeling autosomal recessive cutis laxa type 1C in mice reveals distinct functions for Ltbp-4 isoforms

(2015) I. Bultmann-Mellin et al.   Disease Models & Mechanisms

Gastrointestinal Manifestations, Malnutrition, and Role of Enteral and Parenteral Nutrition in Patients With Scleroderma

(2015) Shishira Bharadwaj et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

EBI3 Downregulation Contributes to Type I Collagen Overexpression in Scleroderma Skin

(2015) Hideo Kudo et al.   JOURNAL OF IMMUNOLOGY

The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-  and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist

(2015) P. Cipriani et al.   JOURNAL OF RHEUMATOLOGY

Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts

(2015) Paola Cipriani et al.   ARTHRITIS RESEARCH & THERAPY

Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis

(2014) Ting Wu et al.   BMC Complementary and Alternative Medicine

Early Systemic Sclerosis: Serum Profiling of Factors Involved in Endothelial, T-cell, and Fibroblast Interplay is Marked by Elevated Interleukin-33 Levels

(2014) Serena Vettori et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Time-dependent and somatically acquired mitochondrial DNA mutagenesis and respiratory chain dysfunction in a scleroderma model of lung fibrosis

(2014) Amiq Gazdhar et al.   Scientific Reports

Latent Transforming Growth Factor β-Binding Protein 4 Is Downregulated in Esophageal Cancer via Promoter Methylation

(2013) Insa Bultmann et al.   PLoS One

LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma

(2012) Han Chen et al.   CANCER LETTERS

Effect of Resveratrol on Treatment of Bleomycin-Induced Pulmonary Fibrosis in Rats

(2012) Recep Akgedik et al.   INFLAMMATION

LTBPs, more than just an escort service

(2012) Vesna Todorovic et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Specificity of latent TGF-β binding protein (LTBP) incorporation into matrix: Role of fibrillins and fibronectin

(2012) Lior Zilberberg et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Update on morphea

(2011) Nicole Fett et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Fingerprint quality detection ofSolanum nigrumusing high-performance liquid chromatography–evaporative light scattering detection

(2011) Liye Wang et al.   PHARMACEUTICAL BIOLOGY

Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas

(2011) Celine Kretschmer et al.   CELLULAR ONCOLOGY

Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis

(2010) Ayumi Yoshizaki et al.   ARTHRITIS AND RHEUMATISM

The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome

(2010) Stephen Ho Kin Chan et al.   INTERNATIONAL JOURNAL OF CANCER

Mechanisms of skin fibrosis in systemic sclerosis

(2010) Masatoshi JINNIN   JOURNAL OF DERMATOLOGY

Attenuation of fibrosis in vitro and in vivo with SPARC siRNA

(2010) Jiu-Cun Wang et al.   ARTHRITIS RESEARCH & THERAPY

Transforming growth factor β as a therapeutic target in systemic sclerosis

(2009) John Varga et al.   Nature Reviews Rheumatology

Latent Transforming Growth Factor-β-Binding Protein-4 Regulates Transforming Growth Factor-β1 Bioavailability for Activation by Fibrogenic Lung Fibroblasts in Response to Bleomycin

(2008) Yong Zhou et al.   AMERICAN JOURNAL OF PATHOLOGY

Role of transforming growth factor-β superfamily signaling pathways in human disease

(2008) Kelly J. Gordon et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Fibronectin and heparin binding domains of latent TGF-β binding protein (LTBP)-4 mediate matrix targeting and cell adhesion

(2008) A KANTOLA et al.   EXPERIMENTAL CELL RESEARCH